Quest Diagnostics Incorporated DGX NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

55/100

1/7 Pass

SharesGrow Intrinsic Value

Quest Diagnostics Incorporated (DGX) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 RUSCKOWSKI STEPHEN H 389,597 주 보유. 기타 주요 보유자에는 Davis J. E. 및 GUINAN MARK.

지난 12개월간 내부자는 95 건의 거래를 수행 DGX 주식 — 47 건 매수 (평가액 $27.31M) 및 18 건 매도 (평가액 $8.15M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

DGX 내부자 보유 현황

최대 보유자

RUSCKOWSKI STEPHEN H

389,597 주

매수 (12개월)

$27.31M 평가액

매도 (12개월)

$8.15M 평가액

12개월 거래 활동

매수 49%

매도 19%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Rusckowski Stephen H	Director	389,597	2023-03-08	100%
2	Davis J. E.	CEO and President	142,423	2026-03-06	37%
3	Guinan Mark	Executive Vice President & CFO	98,981	2022-03-09	25%
4	Doherty Catherine T.	EVP, Regional Businesses	72,680	2026-03-06	19%
5	Eglinton Manner Carrie	SVP, Advanced Diagnostics	48,391	2022-03-09	12%
6	Prevoznik Michael E	SVP & General Counsel	41,435	2026-03-06	11%
7	Cunningham Everett	SVP, Commercial	37,760	2019-03-25	10%
8	Deppe Michael J	SVP, Corp. Controller & CAO	35,196	2026-03-06	9%
9	Samad Sam	Executive Vice President & CFO	33,268	2026-03-06	9%
10	Pfeiffer Gary M	Director	29,431	2025-10-24	8%
11	Stanzione Daniel	Director	28,349	2020-11-24	7%
12	Mendez Manuel O.	SVP & Chief Commercial Officer	27,633	2021-02-22	7%
13	Main Timothy L	Director	26,297	2025-05-19	7%
14	Wilensky Gail R	Director	20,506	2023-05-19	5%
15	Cohen Jon R	SVP & Group Exec. Diag. Sol.	19,464	2018-03-12	5%
16	Plewman Patrick	SVP For Diagnostic Services	18,053	2026-03-06	5%
17	Gregg Vicky B	Director	17,104	2026-02-20	4%
18	Ring Timothy M	Director	17,036	2025-10-03	4%
19	Britell Jenne K	Director	14,479	2018-06-06	4%
20	Kuppusamy Karthik	SVP, Clinical Solutions	13,441	2026-03-06	3%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-04-01	Wentworth Timothy C	Director	RSU 부여	198	-	-
2026-03-09	Wentworth Timothy C	Director	RSU 부여	215	-	-
2026-03-09	Wentworth Timothy C	Director	알 수 없음	-	-	-
2026-03-04	Delaney Mark E	SVP & Chief Commercial Officer	RSU 원천징수	2,326	$204.86	$476.5K
2026-03-04	Kuppusamy Karthik	SVP, Clinical Solutions	정보 매도	2,628	$204.86	$538.37K
2026-03-04	Deppe Michael J	SVP, Corp. Controller & CAO	RSU 원천징수	750	$204.86	$153.65K
2026-03-04	Samad Sam	Executive Vice President & CFO	RSU 원천징수	7,720	$204.86	$1.58M
2026-03-04	Davis J. E.	CEO and President	RSU 원천징수	26,414	$204.86	$5.41M
2026-03-05	Doherty Catherine T.	EVP, Regional Businesses	정보 매도	5,558	$206.21	$1.15M
2026-03-04	Doherty Catherine T.	EVP, Regional Businesses	RSU 원천징수	5,806	$204.86	$1.19M
2026-03-05	Plewman Patrick	SVP For Diagnostic Services	정보 매도	2,855	$206.21	$588.73K
2026-03-04	Plewman Patrick	SVP For Diagnostic Services	RSU 원천징수	2,827	$204.86	$579.14K
2026-03-05	Prevoznik Michael E	SVP & General Counsel	정보 매도	3,878	$206.21	$799.68K
2026-03-04	Prevoznik Michael E	SVP & General Counsel	RSU 원천징수	3,354	$204.86	$687.1K
2026-03-02	Delaney Mark E	SVP & Chief Commercial Officer	RSU 원천징수	188	$204.86	$38.51K
2026-03-02	Kuppusamy Karthik	SVP, Clinical Solutions	RSU 원천징수	205	$204.86	$42K
2026-03-02	Deppe Michael J	SVP, Corp. Controller & CAO	RSU 원천징수	88	$204.86	$18.03K
2026-03-02	Samad Sam	Executive Vice President & CFO	RSU 원천징수	869	$204.86	$178.02K
2026-03-02	Davis J. E.	CEO and President	정보 매도	10,000	$212.52	$2.13M
2026-03-03	Doherty Catherine T.	EVP, Regional Businesses	정보 매도	632	$207.73	$131.29K
2026-03-02	Doherty Catherine T.	EVP, Regional Businesses	RSU 원천징수	648	$204.86	$132.75K
2026-03-03	Plewman Patrick	SVP For Diagnostic Services	정보 매도	410	$207.73	$85.17K
2026-03-02	Plewman Patrick	SVP For Diagnostic Services	RSU 원천징수	230	$204.86	$47.12K
2026-03-03	Prevoznik Michael E	SVP & General Counsel	정보 매도	526	$207.73	$109.27K
2026-03-02	Prevoznik Michael E	SVP & General Counsel	RSU 원천징수	288	$204.86	$59K